Literature DB >> 19576874

Serum levels of gamma-glutamyl transferase are associated with markers of nocturnal hypoxemia in a general adult population.

Francisco Gude1, Jesús Rey-Garcia, Carmen Fernandez-Merino, Luis Meijide, Luis García-Ortiz, Carlos Zamarron, Arturo Gonzalez-Quintela.   

Abstract

BACKGROUND: Serum gamma-glutamyl transferase (GGT) is a well-known marker of alcohol consumption and liver dysfunction. GGT is also associated with components of metabolic syndrome, cardiovascular risk factors and obstructive sleep apnea. In a population-based study, we investigated serum GGT levels in relation to markers of nocturnal hypoxemia, adjusting for potential confounders. In addition, we investigated the possible relationship between GGT concentrations and serum levels of tumour necrosis factor-alpha and interleukin-6.
METHODS: Demographic data, alcohol consumption, components of metabolic syndrome, serum liver enzymes, pro-inflammatory cytokines and nocturnal pulse oximetry were available for 220 individuals, randomly selected from a general adult population. Of these, overnight polysomnography was available for 70.
RESULTS: A smoothing regression model confirmed that serum GGT levels were associated positively and independently with male sex (P<0.001), ageing (P=0.001), heavy smoking (P=0.039), alcohol drinking (P<0.001), and body mass index (P=0.019). Serum GGT levels were associated negatively and independently with average arterial oxygen saturation during sleep (P=0.001).
CONCLUSIONS: Serum concentrations of GGT are associated with nocturnal arterial oxygen desaturations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576874     DOI: 10.1016/j.cca.2009.06.034

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Obstructive sleep apnea and the metabolic syndrome.

Authors:  Zhen-Hua Gao; Ru-Yu Yuan; Kang-Yin Chen; Guang-Ping Li
Journal:  Sleep Breath       Date:  2011-11-13       Impact factor: 2.816

Review 2.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

3.  Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Handan Inonu Koseoglu; Fatih Altunkas; Osman Demir; Sibel Doruk; Ilker Etikan; Ismail Benli
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

4.  Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?

Authors:  Aibek E Mirrakhimov; Vsevolod Y Polotsky
Journal:  Front Neurol       Date:  2012-10-17       Impact factor: 4.003

5.  Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.

Authors:  Arturo Gonzalez-Quintela; Manuela Alonso; Joaquin Campos; Luis Vizcaino; Lourdes Loidi; Francisco Gude
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.